Franziska Schlenker
Papers
1
Total Citations
8
H-Index
1
About
Dr. Franziska Schlenker is a leading innovator in the field of centrifugal microfluidics, with a primary research focus on developing lab-on-a-disk (LabDisk) technologies for advanced biomedical diagnostics. Her most impactful work centers on the automated extraction of cell-free circulating DNA (cfDNA)—a critical emerging biomarker for cancer monitoring and infectious disease diagnostics. In her landmark 2023 study, which has already garnered significant attention with 8 citations, Dr. Schlenker introduced a novel concept for cfDNA extraction using nanobeads as a solid phase within a centrifugal microfluidic platform. This breakthrough enables high recovery rates and fully automated processing, addressing a major bottleneck in liquid biopsy workflows. By ingeniously combining centrifugal forces with nanobead-based capture, her work paves the way for more accessible, rapid, and reliable point-of-care diagnostics. Dr. Schlenker’s contributions are not only advancing the fundamental understanding of microfluidic particle handling but are also directly translating into practical tools for precision medicine, making her a rising star in the intersection of engineering and clinical diagnostics.
Research Focus
Key Achievements
Top Papers
- 1